Literature DB >> 3759085

Osteogenesis imperfecta type IV: evidence of abnormal triple helical structure of type I collagen.

R J Wenstrup, A G Hunter, P H Byers.   

Abstract

Skin fibroblasts from a patient with mild osteogenesis imperfecta (OI) type IV synthesize two populations of type I procollagen molecules. One population contains pro alpha 1(I) and pro alpha 2(I) chains that migrate normally in sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and a second population contains only slower migrating pro alpha 1(I) and pro alpha 2(I) chains. The total amount of type I procollagen made by OI cells and the ratio of pro alpha 1(I):pro alpha 2(I) is normal. When labeled under conditions that inhibit post-translational modification of pro alpha chains, the OI cells produce only single populations of pro alpha 1(I) and pro alpha 2(I) chains indicating that the apparent increased molecular weight of some OI pro alpha chains is due to excessive post-translational modification rather than peptidyl insertions. Peptide maps indicate that excessive post-translational modification occurs along the entire triple helical segment of some alpha 1(I) and alpha 2(I) chains produced by OI cells. The effect of the mutation is to lower the melting temperature of the molecules containing slow migrating alpha 1(I) and alpha 2(I) chains to 39.5 degrees C (compared to 41.5 degrees C for control), and to delay secretion of the over-modified type I procollagen from OI cells. These data are consistent with a mutation near the carboxyl-terminal end of the triple helical domain which delays triple helical formation and renders all chains available for further post-translational modification amino-terminal to the mutation. Such alterations in triple helical structure, thermal stability, and secretion previously associated only with the lethal OI type II phenotype are thus also seen in the mild OI type IV phenotype.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3759085     DOI: 10.1007/bf00278784

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  35 in total

1.  Altered triple helical structure of type I procollagen in lethal perinatal osteogenesis imperfecta.

Authors:  J Bonadio; K A Holbrook; R E Gelinas; J Jacob; P H Byers
Journal:  J Biol Chem       Date:  1985-02-10       Impact factor: 5.157

2.  Intron-mediated recombination may cause a deletion in an alpha 1 type I collagen chain in a lethal form of osteogenesis imperfecta.

Authors:  G S Barsh; C L Roush; J Bonadio; P H Byers; R E Gelinas
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

3.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

Authors:  W M Bonner; R A Laskey
Journal:  Eur J Biochem       Date:  1974-07-01

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  The molecular defect in a nonlethal variant of osteogenesis imperfecta. Synthesis of pro-alpha 2(I) chains which are not incorporated into trimers of type I procollagen.

Authors:  S B Deak; A Nicholls; F M Pope; D J Prockop
Journal:  J Biol Chem       Date:  1983-12-25       Impact factor: 5.157

6.  The mRNAs for the pro-alpha 1(I) and pro-alpha 2(I) chains of type I procollagen are translated at the same rate in normal human fibroblasts and in fibroblasts from two variants of osteogenesis imperfecta with altered steady state ratios of the two mRNAs.

Authors:  W J de Wet; M L Chu; D J Prockop
Journal:  J Biol Chem       Date:  1983-12-10       Impact factor: 5.157

Review 7.  Genetic disorders of collagen metabolism.

Authors:  D W Hollister; P H Byers; K A Holbrook
Journal:  Adv Hum Genet       Date:  1982

8.  Abnormal type I collagen metabolism by cultured fibroblasts in lethal perinatal osteogenesis imperfecta.

Authors:  J F Bateman; T Mascara; D Chan; W G Cole
Journal:  Biochem J       Date:  1984-01-01       Impact factor: 3.857

9.  Use of molecular haplotypes specific for the human pro alpha 2(I) collagen gene in linkage analysis of the mild autosomal dominant forms of osteogenesis imperfecta.

Authors:  C T Falk; R C Schwartz; F Ramirez; P Tsipouras
Journal:  Am J Hum Genet       Date:  1986-03       Impact factor: 11.025

10.  Bone collagen metabolism in vitamin D deficiency.

Authors:  M J Barnes; B J Constable; L F Morton; E Kodicek
Journal:  Biochem J       Date:  1973-01       Impact factor: 3.857

View more
  5 in total

1.  Osteogenesis imperfecta type IV. Biochemical confirmation of genetic linkage to the pro alpha 2(I) gene of type I collagen.

Authors:  R J Wenstrup; P Tsipouras; P H Byers
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

2.  Frameshift mutation near the 3' end of the COL1A1 gene of type I collagen predicts an elongated Pro alpha 1(I) chain and results in osteogenesis imperfecta type I.

Authors:  M C Willing; D H Cohn; P H Byers
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

3.  Distinct biochemical phenotypes predict clinical severity in nonlethal variants of osteogenesis imperfecta.

Authors:  R J Wenstrup; M C Willing; B J Starman; P H Byers
Journal:  Am J Hum Genet       Date:  1990-05       Impact factor: 11.025

4.  Prenatal prediction of osteogenesis imperfecta (OI type IV): exclusion of inheritance using a collagen gene probe.

Authors:  P Tsipouras; R C Schwartz; J D Goldberg; R L Berkowitz; F Ramirez
Journal:  J Med Genet       Date:  1987-07       Impact factor: 6.318

5.  Type I procollagen in the severe non-lethal form of osteogenesis imperfecta. Defective pro-alpha 1(I) chains in a patient with abnormal proteoglycan metabolism and mineral deposits in the dermis.

Authors:  R Tenni; G Cetta; K Dyne; A Rossi; D Quacci; L Lenzi; A A Castellani
Journal:  Hum Genet       Date:  1988-07       Impact factor: 4.132

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.